Jun 30 2023, BioLingus files for Nasdaq IPO
- Biolingus, oral GLP-1 diabetes drug developer,fi les for $47M IPO |
---|
Mar 30 2023, BioLingus to participate in the SWISS-NORDIC BIO Conference in Zürich, Switzerland |
---|
Mar 20-23 2023, BioLingus to participate in the BIO-EUROPE Spring Conference in Basel, Switzerland |
---|
Nov 2022, The Fellowship from the Monash University in Melbourne |
---|
- Thomas Ko, co-founder and CTO of BioLingus receives the Fellowship from the Monash University in Melbourne. The BioLingus team congratulates Tom for this outstanding lifetime achievement !
|
Sept 2022, BioLingus to Develop a Sublingual Vaccine for COVID |
---|
- BioLingus to develop a Sublingual Vaccine for COVID in cooperation with the Korean CHA Vaccine Institute and PanGen Biotech
|
May 19 2022, "Breeding grounds for unicorns" |
---|
- Our CEO Yves Decadt leads a panel discussion on “Breeding grounds for unicorns”, as part of the Horasis International meeting.
|
May 02-03 2022, Swiss Biotech Day in Basel, Switzerland |
---|
- BioLingus will participate in the Swiss Biotech Day in Basel, Switzerland.
|
June 13-16 2022, BIO International Convention in San Diego, USA |
---|
- BioLingus participates in the BIO International Convention in San Diego, USA.
|
March 28-31 2022, BIO Europe SPRING Event (Digital) |
---|
- BioLingus participaties in the BIO Europe SPRING event (Digital).
|
March 15-17 2022, Sir Anthony Ritossa Family Office Investment Summit |
---|
- Yves Decadt, CEO of BioLingus is invited as VIP Speaker at the Sir Anthony Ritossa Family Office Investment Summit in Riyadh, Saudi-Arabia.
|
JAN 2022, Swiss-Nordic BIO conference in Zürich |
---|
- January 25, 2022 : BioLingus participates in the Swiss-Nordic BIO conference held in Zürich. This will be the first face-to-face BIO conference again since two years.
|
NOV 2021, Horasis Asia Conference 2021 |
---|
- November 26th, 2021 : Yves Decadt, CEO of BioLingus will be speaker at the Horasis Asia Conference 2021.
|
OCT 2021, BIO-Europe 2021 |
---|
- October 25-28, 2021 : BioLingus will participate in the BIO-Europe 2021 partnering conference “Building Partnerships in a Digital Age”.
|
SEPT 2021, BioLingus to present at the Swiss Biotech Day |
---|
- What makes this special is that it is our first "live" presentation after the heat of the Covid-crisis. The Swiss Biotech Day has become one of the leading biotechnology conferences in Europe and is a fixed date in the community’s calendar.
While the event could not take place in 2020 due to the worldwide COVID-19 pandemic, the Swiss Biotech Day back on stage on September 7, 2021.
|
JUN 2021, BIO DIGITAL |
---|
- BioLingus is participating in the BIO DIGITAL partnering conference from June 14-18
|
MAY 2021, Superior efficacy of SUBLINGUAL BioLingus formulation of interferon in oncology |
---|
- Publication: Ciccolella et al, Cells. 2021 Apr 8; 10 (4):845 : “Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor Models”
|
MAY 2021, BioTechGate Digital Partnering |
---|
- BioLingus will join the BioTechGate Digital Partnering event from May 3rd to May 7th 2021.
|
FEB 2021, Swiss Nordic BIO conference |
---|
- February 10-11, 2021 : BioLingus is participating at the 2021 Swiss Nordic BIO conference.
|
JAN 2021, BIO One-on-One Partnering |
---|
- January 11-15, 2021 : BioLingus is participating at the 2021 BIO One-on-One Partnering@JPM.
|
Nov 2020, Swiss Chinese Chamber of Commerce in Zürich |
---|
- BioLingus in interview with the Swiss Chinese Chamber of Commerce in Zürich on the role
and importance of China for a biotech company like ours.
|
Oct 2020, Yves Decadt, CEO of BioLingus, is chairing the Horasis panel in “Inspiration in Social Innovation”. |
---|
- Some innovators and entrepreneurs see glory as a goal, partly by making a profit. But profit alone is not enough – social betterment and ethical application with positive impacts are better goals. How can entrepreneurs ride high on social innovation ?
|
Jul 2020, BioLingus “backstage” at BIO2020 |
---|
- Zoom interview on BioLingus and the impact of Covid19 on the biotech and healthcare industry.
|
Mar 2020, New VP Pharmaceutical Development and Site Head Basel Lab |
---|
- BioLingus appoints Dr Guy Vergnault as new VP Pharmaceutical Development and Site Head Basel Lab
|
Mar 2020, A new lab in Switzerland Innovation Park Basel Area |
---|
- BioLingus starts a new lab in Switzerland Innovation Park Basel Area
|
JAN 2020, BioLingus participating in Peptalk 2020 |
---|
- BioLingus participating in Peptalk 2020.
|
NOV 2019, Interview of Thomas Ko, CTO of BioLingus by the Monash university |
---|
- Interview of Thomas Ko, CTO of BioLingus by the Monash university
|
NOV 2019, Bio-Europe in Hamburg |
---|
- BioLingus participating in the Bio-Europe partnering conference in Hamburg.
|
Oct 2019 |
---|
- We are happy to announce that Dr Ken Pang has been appointed to Associate Professor, Department of Paediatrics, The University of Melbourne. |
JUN 2019, BIO Conference in Philadelphia |
---|
- BioLingus participating in the BIO Conference in Philadelphia .
|
MAY 2019, HKEX Biotech Summit |
---|
- Yves Decadt, CEO BioLingus, will speak at the HKEX Biotech Summit on May 2019. More information can be found at www.hkexgroup.com |
APR 2019, 2019 Global Venture Award |
---|
- BioLingus is proud winner of the 2019 Global Venture Award. |
APR 2019, Horasis Global meeting in Cascais (Portugal) |
---|
-BioLingus to speak at Horasis Global meeting in Cascais (Portugal) in the session “Breakthrough technologies for the future” More details: From the time of Jules Verne we have been assailed by stories of the next great breakthrough: presently we have 3D-printing, cloud-based AI services and, even gene therapies.What do you think will change our future? How long will they take to be popular, or affordable? Will the modern Luddites rise up against them?” |
FEB 2019, WuXi STA and BioLingus sign exclusive technology and marketing collaboration for sublingual delivery |
---|
- ZURICH, SHANGHAI and SAN DIEGO, February 19, 2019 |
FEB 2019, BioLingus to attend the Swiss-Nordic BioConference |
---|
- BioLingus to attend the Swiss-Nordic BioConference. Swiss Nordic Bio is the number one platform that gathers life science professionals from Switzerland and the Nordic countries.
|
JAN 2019, Drug Delivery Partnerships, USA |
---|
-BioLingus will participate in Drug Delivery Partnerships, on 28-30th January 2019 at Palm Beach Gardens, USA |
NOV 2018, Bio-Europe, Denmark |
---|
-BioLingus will participate in Bio-Europe on 5-7th November 2018 at Copenhagen, Denmark. |
AUG 2018, BioLingus receives Award for “Best European Biotech Company 2018” |
---|
-We are humbled and at the same time very proud with this European award as a tribute to the day to day efforts, creativity and perserverance of our BioLingus Team !
|
MAY 2018, Horasis Global Meeting, Cascais, Portugal |
---|
-BioLingus will speak at this Global Horasis meeting, in the section on “Spearheading economic growth”.
|
APR 2018, 2018 Red Herring Top 100 Award |
---|
- Amsterdam, April 18th, 2018 : “BioLingus proud winner of the 2018 Red Herring Top 100 Award”
|
APR 2018, Red Herring Top 100 conference in Amsterdam |
---|
-BioLingus to present at the Red Herring Top 100 conference in Amsterdam, April 17-18th - BioLingus is nominated for the Red Herring Top 100 2018 !
|
FEB 2018, 11th Annual European Life Sciences CEO Forum and Exhibition |
---|
-BioLingus to present at the 11th Annual European Life Sciences CEO Forum and Exhibition, 26th-27th February 2018, Hilton Zurich Airport Hotel, Switzerland.
|
JAN 2018, New Analyst Report from Alpha Deal Group |
---|
- New analyst report from Alpha Deal Group available on BioLingus titled: “Strong potential : transforming the way medicines work”.
|
DEC 2017, BioLingus signs Agreement with the Tücher Group - China in focus |
---|
-BioLingus signs collaboration agreement with the Tücher group. Aim is to commercialize the BioLingus series of food supplements via a new Joint Venture in China.
Our food supplements are based on the same innovative and proprietary technology as our pharmaceuticals, but compared to our bio-pharmaceutical products, food supplements may generate revenues in a shorter time.
Being innovative Swiss products, our food supplements will be positioned in the premium & high price market segment in China.
|
NOV 2017, EuroTides conference 2017 in Vienna |
---|
- BioLingus will be presenting at the EuroTides conference in Vienna on 8 NOV 2017. |
OCT 2017, BioLingus in list of "Top 20 Most Influential Companies" from CEO Insight |
---|
-This year's companies include Abbvie, TEVA, Vertex, SAS Institute, LinkedIn, Coca Cola, Deloitte, PWC and others, so a mix of large and smaller companies, with a shared characteristic as the authors describe it : "CEO Insight’s Top 20 Most Influential Companies list acknowledges enterprises that have a vision that shapes the conceptual landscape of inward investment, finance, business, technology, design, architecture and law."
|
OCT 2017, Blockbuster Potential: How Biotech is Paving the Way to Clear Skin from Psoriasis |
---|
-Review article on the future of psoriasis treatments, mentioning not only BioLingus, but also Janssen (JNJ), Astrazeneca, Leo Pharma, Amgen, Boehringer Ingelheim and Abvie.
|
SEP 2017, 17th Annual Biotech in Europe Forum(aka the Sachs conference) |
---|
- Yves Decadt, CEO of BioLingus, will be speaking at the 17th Annual Biotech in Europe Forum (aka the Sachs conference), and will be member of the diabetes and obesity panel. |
JULY 2017, Two prestigious awards from CEO Monthly Magazine |
---|
- We are pleased to announce that the CEO Monthly Magazine has presented two prestigious awards to BioLingus : Best European CEO Biotech – Europe, Most Innovative Biotech company – Europe
. |
JUNE 2017, 2017 Horasis Meeting in Interlaken, Switzerland |
---|
- BioLingus will be presenting at the 2017 Horasis Meeting on June 25-26 in Interlaken, Switzerland. |
MAY 2017, ACQ 2017 Global Awards Program |
---|
-For the second time, BioLingus has been awarded the “GAMECHANGER AWARD” in the category Biotech from the ACQ 2017 Global Awards Program. |
MAY 2017, 2017 Sino-Europe BioPartnering(SEBP)conference in Shanghai |
---|
- BioLingus will be presenting at the 2017 Sino-Europe BioPartnering (SEBP) conference in Shanghai, China on 15-16 May 2017. |
APR 2017, TIDES conference in April 2017 in San Diego |
---|
- BioLingus will present its technology at the TIDES conference in April 2017 in San Diego. |
JAN 2017, 2016 ACQ annual awards |
---|
- BioLingus is proud to be the winner of the “Gamechanger Award” and “European Biotech Award” 2016 from the ACQ annual awards program”. |
NOV 2016, 2016 Business Worldwide Magazine Awards |
---|
- BioLingus CEO Scoops Two Wins in Business Worldwide Magazine Awards. |
NOV 2016, Best Delivery System from the Global Health & Packaging magazine |
---|
- BioLingus wins Best Delivery System Award from the Global Health & Packaging magazine. |
NOV 2016, 2016 Business Worldwide Magazine Awards |
---|
- BioLingus CEO Scoops Two Wins in Business Worldwide Magazine Awards. |
NOV 2016, Biolingus article in Business Worldwide Magazine |
---|
- BioLingus Article in Business Worldwide Magazine
"The non-invasive delivery of biological drugs: a holy grail in the pharmaceutical industry?" |
Jan 2017, 35th Annual Healthcare Conference |
---|
- BioLingus will participate in the “J.P. Morgan 35th Annual Healthcare Conference” in January 2017 in San Francisco. |
Nov 2016, 2016 Bio-Europe conference |
---|
- BioLingus will participate in the Bio-Europe conference in Germany. |
Sep 2016, Wuxi Apptec and BioLingus enter into Co-Marketing Agreement |
---|
|
Jul 2016, Yves Decadt, Biolingus CEO explains the innovative technology in EUROPEANCEO |
---|
- Yves Decadt, Biolingus CEO explains the innovative technology that takes injectable medicines and transforms them into pills. |
Jul 2016, EUROPENCEO Interview with Yves Decadt, CEO, BioLingus |
---|
- Inspiration from nature is transforming how medicines work - EUROPENCEO Interview with Yves Decadt, CEO, BioLingus. |
Jun 2016, BIO International Convention 2016 |
---|
- Yves Decadt, CEO of BioLingus, will participate in 2016 BIO International Convention on June 6-9 at Moscone Center, San Francisco, California. |
May 2016, 2016 European CEO Magazine Awards |
---|
- BioLingus has been selected as the winner of the 2016 award in the section "MOST INNOVATIVE BIOTECH COMPANY” from the European CEO magazine. Awards will be presented during the 2017 WEF in Davos. |
Feb 2016, Swiss-Scandinavian Bio-Business Seminar |
---|
- Yves Decadt, CEO of BioLingus, will participate in 10th Swiss-Scandinavian Bio-Business Seminar 2016 on February 10 at the SIX Swiss Exchange in Zurich. |
Jan 2016, Drug Development Partnerships |
---|
- Yves Decadt, CEO of BioLingus, will participate in Drug Development Partnerships, Palm Beach Gardens, FL, United States, on 20-22 Jan 2016. |
Nov 2015, Bio-Europe 2015 |
---|
- Yves Decadt, CEO of BioLingus, will present at Bio-Europe 2015, Munich Germany, on 2-4 Nov 2015. |
Sept 2015, Peptide Therapeutic Forum, MipTec Congress 2015 |
---|
- Yves Decadt, CEO of BioLingus, will present at Peptide Therapeutic Forum, MipTec Congress 2015, Basel (CH) on 22-23 Sept 2015. |
Jun 2015, Alpine High-tech Venture Forum, Lausanne |
---|
- BioLingus will participate in the Alpine High-Tech Venture Forum in Lausanne, 24-25 June 2015. |
Jun 2015, Bio International Convention |
---|
- BioLingus will participate in the Bio International Convention, June 15-18, Philadelphia, USA. |
May 2015, Sino-European Bio-Partnering(SEBP) |
---|
- Yves Decadt, CEO of BioLingus, will present at the at the Sino-European Bio-Partnering (SEBP) in Shanghai China on 14th May 2015. |
Mar 2015, INARTIS Drug Delivery Event in Zürich |
---|
- Yves Decadt, CEO of BioLingus, will present at the INARTIS Drug Delivery Event in Zürich, 23rd March 2015. |
Feb 2015, Venture Summit | West 2015 |
---|
- Yves Decadt, CEO of BioLingus, will present at Venture Summit West 2015, Palo Alto, USA. |
Feb 2015, 9th Swiss-Scandinavian Bio-Business Seminar |
---|
- BioLingus will participate in 9th Swiss-Scandinavian Bio-Business Seminar, 5th February 2015. |
Feb 2015, Swiss HLG Winter Conference |
---|
- BioLingus will participate in Swiss HLG Winter Conference, Flims February 2015. |
Nov 2014, Bio-Europe Partnering conference in Frankfurt |
---|
- BioLingus will participate in Bio-Europe Partnering conference in Frankfurt, Germany. |
Oct 2014, BioLingus drug delivery patent has been granted in USA in addition to Australia |
---|
- Message from the CEO : "I am happy to communicate that this month, our drug delivery patent WO2012/109694 A1 has been granted in USA in addition to Australia. This is an important step in the strengthening of our patent portfolio for the most important pharmaceutical territory, which is still USA. We are confident that other important territories will follow. This also demonstrate our company with our breakthrough technology is able to deliver real novelty, to change the way how peptides and proteins are administered in the future. With this, I want to especially thank Mr. Thomas Ko, who is the key inventor of this patent and also CTO of BioLingus." |
Oct 2014, The 11th Swiss CEO day in Bern, Switzerland |
---|
- Yves Decadt, CEO of BioLingus, will participate in the 11th Swiss CEO day in Bern, Switzerland. |
Sept 2014, The 14th Annual Biotech in Europe Forum |
---|
- Yves Decadt, CEO of BioLingus, will present at the 14th Annual Biotech in Europe Forum, 30th September - 1st October 2014, Basel Congress Centre, Switzerland. |
Jun 2014, 2014 BIO International Convention |
---|
- BioLingus will participate in the Bio Conference in San Diego, 23-36 June 2014. |
Jun 2014, BIT"s 1st Annual Global Innovation Economic Congress |
---|
- Yves Decadt, CEO of BioLingus and Tom Ko, CTO of BiolLingus are invited as speaker on Bit congress forum 1013&1015 from June 26-29 2014. |
Mar 2014, 7th Annual European Life Science CEO Forum in Zurich |
---|
- Yves Decadt, CEO of BioLingus, will present at the 7th Annual European Life Science CEO Forum taking place on 4th-5th March 2014 at Hilton Zurich Airport Hotel. |
Feb 2014, Swiss Healthcare Licensing Conference |
---|
- We participate in the Swiss Healthcare Licensing Conference in Flims (Switzerland), from February 2-4. |
Jan 2014, Drug Delivery Partnership conference in Miami |
---|
- Yves Decadt, CEO of BioLingus, will present in January 2014 on the Drug Delivery Partnership conference in Miami. |
Jan 2014, JP Morgan Health conference in San Francisco |
---|
- We participate in the JP Morgan Health conference in San Francisco mid January |